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Summary
Genetic strategies for perturbing activity of selected
neurons hold great promise for understanding cir-
cuitry and behavior. Several such strategies exist,
but there has been no direct demonstration of revers-
ible inactivation of mammalian neurons in vivo. We
previously reported quickly reversible inactivation of
neurons in vitro using expression of the Drosophila
allatostatin receptor (AlstR). Here, adeno-associated
viral vectors are used to express AlstR in vivo in corti-
cal and thalamic neurons of rats, ferrets, and mon-
keys. Application of the receptor’s ligand, allatostatin
(AL), leads to a dramatic reduction in neural activity,
including responses of visual neurons to optimized
visual stimuli. Additionally, AL eliminates activity in
spinal cords of transgenic mice conditionally express-
ing AlstR. This reduction occurs selectively in AlstR-
expressing neurons. Inactivation can be reversed
within minutes upon washout of the ligand and is
repeatable, demonstrating that the AlstR/AL system
is effective for selective, quick, and reversible silenc-
ing of mammalian neurons in vivo.
Introduction
A major goal of systems neuroscience is to elucidate the
roles of individual cell types within complex neural cir-
cuits and to understand their contributions to percep-
tion and behavior. To this end, several laboratories
have developed genetically encoded modulators of neu-
ral activity. The primary advantage of genetic methods is
that expression can be targeted to the cell type(s) of
interest (Callaway, 2005; Gong et al., 2003); modulation
of activity in targeted cells can then allow investigation
of the contributions of specific cell types.
Genetic strategies for manipulating neural activity dif-
fer in their degree and speed of reversibility as well as
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6 These authors contributed equally to this work.other factors that influence their utility for in vivo manip-
ulation. Because any given experimental paradigm will
have unique goals and limitations, no single method
will be ideal for all future applications. Pioneering
genetic strategies selectively and irreversibly ablated
targeted cells (Isles et al., 2001; Kobayashi et al.,
1995). Methods developed subsequently possess the
potential for reversibility via temporally regulated gene
expression. For instance, neurons have successfully
been silenced, sometimes reversibly, using K+ channel
overexpression (Ehrengruber et al., 1997; Johns et al.,
1999; Nitabach et al., 2002). Another highly effective
strategy blocks receptors and channels via toxins teth-
ered to the plasma membrane (Ibanez-Tallon et al.,
2004). These approaches offer slow temporal regulation
at best, and are thus best suited for studies requiring
long-term inactivation. The inability to achieve more
transient inactivation presents difficulties related to
compensatory changes: K+ channel overexpression,
for instance, has yielded unwanted side effects such
as cell death and hyperexcitability (Nadeau et al., 2000;
Sutherland et al., 1999).
To minimize effects caused by long-term changes in
excitability, more recent efforts have adopted strategies
with faster timescales of reversibility. Light-based
methods for eliciting or inhibiting spiking in neurons
(Banghart et al., 2004; Boyden et al., 2005; Li et al.,
2005; Lima and Miesenbock, 2005; Zemelman et al.,
2002, 2003) offer extremely fast temporal control, as
they are limited largely by the speed and efficiency of
light delivery. Impressive effects have been demon-
strated in the intact embryonic chicken spinal cord (Li
et al., 2005). Difficulties related to delivery of light in
deep neural tissues are likely, however, to prove prob-
lematic for many in vivo applications.
Pharmacologically based methods for inhibiting spik-
ing or synaptic transmission (Coward et al., 1998; Kar-
pova et al., 2005; Lechner et al., 2002; Slimko et al.,
2002) allow access to deep tissues while retaining the
potential for quick temporal control. Although several
factors could reduce the temporal resolution of such
methods, in vitro studies have demonstrated that
methods based on G protein-coupled activation of K+
channels can be very fast (milliseconds to minutes)
and are therefore, in theory, limited only by the speed
with which ligand can be effectively applied and re-
moved from the system (Coward et al., 1998; Lechner
et al., 2002).
Despite the great promise of these varied ap-
proaches, no reversible method has directly demon-
strated in vivo inactivation of neurons in a mammalian
system. The Molecules for Inactivation of Synaptic
Transmission (MIST) approach (Karpova et al., 2005),
based on reversible blocking of synaptic transmission,
has been shown to elicit behavioral deficits following
application to mouse cerebellar Purkinje cells; in this
study, however, in vivo neural activity was not directly
assayed. The MIST system is reversible in vivo on a
timescale of hours to days and is likely to prove ex-
tremely useful for applications requiring long periods
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158Figure 1. Diagrams of Plasmids Used to
Make Viruses in This Study
These diagrams illustrate the genetic con-
structs placed in the AAV backbone and
therefore carried into infected cells by virus.
(A) AlstR viruses. A synapsin promoter was
used to drive expression of AlstR; an IRES2
element was used to obtain additional
expression of EGFP. The construct was iden-
tical for both AAV1 and AAV2 viruses. (B)
Control viruses. EGFP expression was driven
by a CMV promoter (AAV1 construct) or by a
synapsin promoter (AAV2 construct). AAV1
was used in cortical experiments; AAV2 was
used in thalamic experiments.of inactivation without fast onset or recovery. For
many physiological studies, however, the ideal sys-
tem would elicit inactivation within minutes, would
allow inactivation to persist for an hour or longer, and
could allow temporally controlled recovery within
minutes.
Here, we present such a genetic system for use in
mammalian neurons in vivo. In a previous report, we
demonstrated selective, quickly reversible inactivation
of ferret cortical neurons in vitro using the allatostatin
receptor/allatostatin (AlstR/AL) system (Birgul et al.,
1999; Lechner et al., 2002). AL effectively reduced mem-
brane potential and input resistance by opening G
protein-coupled inward-rectifying K+ (GIRK) channels
in AlstR-expressing neurons in vitro, indicating that it
may be capable of inactivating neurons in vivo. Here,
we overcome many of the difficulties inherent in genetic
manipulation and direct assay of neuronal activity in or-
der to study the efficacy of the AlstR/AL system in vivo.
Using adeno-associated viral (AAV) vectors to express
AlstR in mammalian neurons, we demonstrate that the
AlstR/AL system is effective for quick and reversible
inactivation of rat and ferret cortical neurons, as well
as ferret and monkey thalamic neurons, in vivo. Addi-
tionally, we demonstrate that AL can effectively silence




AAV vectors were used to express AlstR in several dif-
ferent preparations, including the rat barrel cortex, ferret
visual cortex, and lateral geniculate nucleus (LGN) of
ferrets and monkeys. Experiments conducted in rat bar-
rel cortex tested for inactivation of in vivo cortical activ-
ity generated by strong and synchronous activation of
afferent input following electrical stimulation of the whis-
ker pad. Experiments conducted in the LGN (ferrets and
monkeys) and visual cortex (ferrets) tested the ability of
AL to eliminate responses to visual stimuli in vivo. In
additional experiments, AlstR was expressed condition-
ally in transgenic mice following Cre recombination.
These experiments examined the effects of AL on the
activity of motor neurons in an in vitro, isolated spinal
cord preparation. In all preparations, the ability of AL
to induce inactivation was tested both in neurons
expressing AlstR and in control neurons not expressing
AlstR.Viral Constructs
To achieve AlstR expression, AAVs were used to deliver
genetic constructs (Figure 1). Due to differences in
transduction efficiency, AAV serotype 1 (AAV1) was
used in cortical experiments, while AAV serotype 2
(AAV2) was used in LGN experiments. AlstR expression
was under the regulation of the neuron-specific synap-
sin promoter, which drives expression indiscriminately
in all neuron types; an IRES2 element drove additional
expression of EGFP as a marker for virus-infected,
AlstR-expressing cells (Figure 1A). For control experi-
ments, AAVs encoding only EGFP under the CMV or syn-
apsin promoter were used (Figure 1B). For simplicity, we
will refer to the AlstR-encoding viruses as ‘‘AAV1-AlstR-
EGFP’’ and ‘‘AAV2-AlstR-EGFP;’’ the control viruses will
be referred to as ‘‘AAV1-EGFP’’ and ‘‘AAV2-EGFP.’’
Inactivation of Neurons in Rat Barrel Cortex
To examine whether the AlstR/AL system could ef-
fectively silence cortical cells in rat, we injected
AAV1-AlstR-EGFP into the barrel cortex of adult rats.
Following at least 35 days to allow expression of the
delivered genes, local field potentials (LFPs) evoked by
electrical stimulation of the whisker pad were recorded
from virus-injected sites of anesthetized rats (see
Experimental Procedures). Subsequent histological
staining was used to determine whether virus injection
resulted in successful AlstR/EGFP expression and
whether the recordings were made from the region of
AlstR expression.
Figure 2 shows representative LFPs recorded from
a region of AlstR expression in the barrel cortex of
a rat. Recordings included a large stimulus artifact
coinciding with the onset of whisker pad electrical stim-
ulation. A large positive voltage deflection typically
appeared about 7 ms after the stimulus artifact, followed
by a sizeable negative deflection and sometimes by
additional small fluctuations in voltage. An example
response is illustrated in Figure 2A for a recording
made prior to application of AL in a cortical region that
was later confirmed to coincide with a region of AlstR
expression (Figure 3A2). Following application of 0.1 mM
AL directly onto the cortical surface, the stimulus-
evoked response was essentially eliminated (Figure 2B)
and then returned following washout of the AL with
saline (Figure 2C). After several rounds of repeated inac-
tivation with AL (see below), effects of the GABAA
agonist muscimol were characterized for comparison,
since muscimol should maximally inactivate cortical
Reversible Inactivation of Mammalian Neurons
159Figure 2. Representative Local Field Poten-
tials Recorded from the Barrel Cortex of
a Rat Expressing AlstR
Recordings are in response to electrical stim-
ulation of the whisker pad. Example LFPs are
illustrated in chronological order: (A) prior to
application of AL to the cortical surface; (B)
11 min after application of AL; (C) 10 min after
washout of AL with saline; and (D) 20 min after
application of muscimol. AL application
resulted in complete elimination of stimulus-
evoked LFP, comparable to the effects of
muscimol, and washout resulted in complete
recovery. Asterisks indicate the electrical
stimulus artifact, which was not affected by
AL or muscimol.responses. Figure 2D shows that the stimulus-evoked
LFP following inactivation with muscimol is similar to
that observed following AL application (Figure 2B).
To test the speed of inactivation and recovery follow-
ing application and washout of AL, whisker stimulation-
evoked LFPs were recorded at 10 s intervals. Peak LFPs
measured over the entire course of the same experiment
for which representative recordings are shown in Fig-
ure 2 are plotted in Figure 3A1. An example from a
second rat is shown in Figure 3B1. In both examples,
neurons inactivated within minutes of 0.1 mM AL applica-tion and recovered nearly completely within minutes of
saline washout. This effect was repeatable, indicating
that the AlstR/AL system can inactivate neurons repeat-
edly without apparent desensitization. Longer AL appli-
cations result in longer-lasting inactivation (Figure 3B1,
second AL application), suggesting that the duration of
AlstR/AL-mediated inactivation is dictated by the pres-
ence of AL, rather than being short-lived (see further re-
sults below). Moreover, a dose of 0.1 mM AL appears to
be sufficient to elicit maximal inactivation in this experi-
mental paradigm, as increasing the dose 10-fold doesFigure 3. The AlstR/AL System Quickly and
Reversibly Eliminates Stimulus-Evoked
LFPs in Rat Barrel Cortex
(A1–C1) Peaks of LFPs evoked at 10 s inter-
vals, plotted over time, from rats infected
with AAV1-AlstR-EGFP (A1–B1) and a control
rat infected with AAV1-EGFP (C1). Letters
a–d in panel A1 correspond to the times of
LFP recordings illustrated in Figure 2 (panels
[A]–[D], respectively), which were from the
same animal. Field potential responses dis-
appear within minutes of AL application in
AlstR-expressing neurons and recover within
minutes of washout; the effect is repeatable.
(A2–C2) Sagittal sections from rats shown in
(A1)–(C1), respectively, demonstrating EGFP
expression (black staining) and recording
sites (lesions indicated by white arrows).
Scale bar, 200 mm; top, pia; left, anterior. In
all cases, recordings were made from the
area of EGFP expression.
(D) Average LFP responses6 SEM from three
AlstR-expressing and three control rats.
Averages represent responses relative to
baseline during the 3 min after application
of 0.1 mM AL or saline; data were pooled
across AL applications for each animal (see
Experimental Procedures for details). LFPs
inactivated upon AL application and recov-
ered to baseline levels in AlstR-expressing
rats; no effect was observed in control rats.
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AL application). Comparison of the effect of AL applica-
tion to the effect of muscimol suggests that inactivation
was more complete in the example shown in Figure 3A
than in Figure 3B. This may be related to less efficient in-
fection in the latter case, as suggested by the weaker
EGFP staining in superficial cortical layers (compare
Figure 3A2 with Figure 3B2).
No effect was observed when AL was applied to the
cortex of control rats injected with AAV1-EGFP, even
when 100-fold higher AL concentrations (10 mM) were
applied (Figure 3C1). Summary data from three AlstR-
expressing and three control rats are shown in Figure 3D.
To quantify inactivation, responses to AL application
were compared to responses to muscimol application.
Muscimol was presumed to result in complete inactiva-
tion, so peak LFPs measured following muscimol were
defined as a baseline below which LFPs could not fall.
Inactivation following AL application was expressed as
a percentage of the difference between the peak LFP
before AL application and the baseline LFP following
muscimol application (see Experimental Procedures).
On average, neurons from the AlstR-expressing rats in-
activated to 28.2% 6 14.9% of baseline levels upon AL
application and recovered to 108.9%6 9.9% of baseline
levels after washout of AL. (0% corresponds to com-
plete inactivation while 100% corresponds to no effect/
complete recovery.) Neurons from control rats did not
inactivate, their responses remaining at 101.6% 6
11.7% of baseline levels upon AL application. Similar
values were obtained when field potential areas, rather
than peaks, were analyzed (inactivation to 25.9% 6
13.4% of baseline and recovery to 115.8% 6 8.0% for
AlstR-expressing rats; 101.3% 6 12.9% of baseline fol-
lowing AL application for controls; see Experimental
Procedures for details of analysis). In all cases included
in this analysis, we had histological confirmation that
recordings were made from the virus-infected region
of cortex (Figures 3A2, 3B2, and 3C2).
The incomplete inactivation observed in some AlstR-
expressing rats is likely due to the fact that LFPs reflect
responses from many neurons, including both AlstR-
expressing and nonexpressing neurons: the non-AlstR-
expressing neurons presumably retain their activity
upon AL application, resulting in residual activity in the
field potential response. An alternative possibility, how-
ever, is partial inactivation of AlstR-expressing neurons
and/or variability in the levels of AlstR expression. This
ambiguity prompted us to perform single-unit record-
ings in ferret visual cortex, as described below.
Inactivation of Neurons in Ferret Visual Cortex
The rat somatosensory cortex experiments described
above indicate that the AlstR/AL system can effectively
inactivate LFP activity in a reversible fashion. However,
because field potential recordings reflect both presyn-
aptic and postsynaptic activity from a population of
neurons, the response of individual neurons remained
unclear, particularly in cases where inactivation was in-
complete. To clarify this issue, and to assess responses
to AL using a sensory stimulus rather than an artificial
electrical stimulus, we performed a series of single-
and multi-unit recordings from visual cortical neurons
of adult ferrets.In this set of experiments, AAV1-AlstR-EGFP was in-
jected into Area 17 of adult ferrets. After establishment
of transgene expression, extracellular recordings were
made from the virus-infected area in anesthetized, par-
alyzed ferrets. Ferrets viewed drifting grating visual
stimuli while AL or saline was applied to the brain sur-
face. After recordings were completed, ferrets’ brains
were sectioned, stained with an anti-EGFP antibody,
and examined to locate the recording site and its rela-
tionship to regions of viral infection.
After infection with the AlstR-encoding virus and prior
to application of AL, visual cortical cells exhibited appar-
ently normal visual response properties. Figure 4 shows
the tuning properties of an example unit, recorded in
cortical layer 5 at a depth of 880 mm from the pial sur-
face, from an AlstR-expressing region of ferret cortex
before application of AL. This unit had strong orientation
tuning, moderate direction selectivity, and bandpass
spatial frequency tuning. All units studied (n = 5) were
tuned for values typical of ferret Area 17 neurons (Alitto
and Usrey, 2004; Baker et al., 1998). Cells had preferred
spatial frequencies of 0.02–0.32 cycles/deg and optimal
temporal frequencies of 1–10 Hz. Nearly all cells exam-
ined were orientation-tuned and had bandpass spatial
frequency tuning.
Application of 0.1 mM AL to the cortical surface com-
pletely abolished both spontaneous and visually evoked
activity of the unit characterized in Figure 4 (Figure 5A1).
Activity dropped to 8% of baseline levels within 5 min of
AL application, with complete inactivation occurring 30
s later. Upon saline washout, administered 11 min after
AL application, activity did not recover immediately:
recovery began to occur 30 min after washout, reaching
a peak of 57% of baseline 40 min after washout (see
Experimental Procedures for details of analysis). This
result was typical of our ferret cortical recordings, and
Figure 4. Tuning Properties of a Visual Cortical Neuron from a Ferret
Expressing AlstR
Separate plots indicate visual responses to drifting sinusoidal grat-
ings with varying stimulus orientation, spatial frequency, temporal
frequency, or contrast. Each point indicates the mean firing rate 6
SEM for two presentations of each stimulus; dotted lines indicate
mean response 6 SEM to a blank stimulus. In the absence of AL,
responses of this neuron are typical for a layer 5 ferret visual cortical
neuron; this neuron’s activity in the presence of AL is shown in
Figure 5A.
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(A1 and B1) Mean firing rate (y axis) versus time (x axis) for AlstR-expressing (A1) and EGFP control (B1) ferrets. (A1) is a single-unit recording; (B1)
is a multi-unit recording. In both plots, responses are to drifting grating stimuli of 99% and 35% contrast (black squares and dark gray circles,
respectively); stimuli were optimized for spatial and temporal frequencies. Light gray triangles indicate responses to blank stimuli; the dashed
line indicates a firing rate of 0 spikes/s. Timing of saline, AL, and muscimol applications to the cortical surface are indicated above each plot. The
unit from the AlstR-expressing ferret (A1) inactivated quickly and completely in response to 0.1 mM AL and began to recover 30 min after saline
wash; units from the control ferret (B1) did not inactivate, even at 10- and 100-fold higher AL concentrations. Muscimol inactivated the control
units, indicating that they did not correspond to recordings from afferent axons.
(A2 and B2) Histology from ferrets shown in A1 and B1, respectively. Antibody staining for EGFP (black staining) reveals area of virus infection;
lesion in (A2) and electrode track in (B2) (white arrows) mark recording sites. Scale bars, 250 mm.
(C) Summary data from three AlstR-expressing ferrets and four controls (two EGFP, two uninjected). Neurons from AlstR-expressing ferrets in-
activated to 3.3%6 2.4% of baseline firing rates in response to AL application and recovered to 53.5%6 3.7% of baseline; neurons from control
ferrets fired at 97.0% 6 14.3% of baseline levels after AL was applied.contrasts with the results of our rat LFP experiments, in
which complete recovery was achieved within minutes
of saline wash. The lack of full recovery is likely to be
due in part to loss of unit isolation over the course of
the experiment: since it is not possible to monitor
changes in spike shape or amplitude for units that are in-
active, a fully recovered unit might sometimes fail to
meet the spike shape criteria required for inclusion.
The difference in recovery time likely reflects a difference
in ability to remove AL from the cortical surface: in the
ferret, unlike in the rat, a large physical gap exists
between the skull and the brain, making it difficult to
replace fluids once they are applied. In analogousexperiments performed in ferret LGN, where surround-
ing brain structures do not permit washout of AL, we
observed a similar time course of recovery from AL-
induced inactivation (see below).
Figure 5C shows summary data from the three AlstR-
expressing ferrets examined in this study. Cells from
AlstR-expressing ferrets fired at 3.3% 6 2.4% of base-
line levels (in the 5–10 min time interval) following AL
application and typically recovered to 53.5% 6 3.7%
of baseline within 35–80 min of saline washout (see
Experimental Procedures for details of analysis). Pro-
cessed brain sections from the ferret represented in Fig-
ure 5A1 provided visual confirmation that recordings
Neuron
162were made from the region of virus infection (Figure 5A2).
In the remaining ferrets, where histology was not recov-
ered, correct placement of the electrode was inferred, as
inactivation was never observed in non-AlstR-express-
ing ferrets.
AL had no effect on visual responsiveness or sponta-
neous firing of Area 17 neurons in control ferrets (n = 2
ferrets, three recordings) infected with AAV1-EGFP (Fig-
ures 5B1 and 5C). This was true even when 100 times the
effective dose of AL was applied. Application of the
GABAA agonist muscimol resulted in complete inactiva-
tion of the neurons (Figure 5B1), confirming that record-
ings were from cortical neurons rather than from afferent
fibers, which would have been unresponsive to AL re-
gardless of the virus used. In all cases, examination of
processed brain sections confirmed that recordings
were made from the region of virus infection (see
Figure 5B2 for an example). These results indicate that
virus infection alone does not confer sensitivity to AL.
Similar results were observed in recordings made in
noninjected hemispheres of virus-injected ferrets (n =
2 ferrets, two recordings). On average, neurons from
EGFP-expressing and normal controls fired at 97.0% 6
14.3% of baseline levels following application of AL
(Figure 5C). These results, combined with our observa-
tions in rat, support our conclusion that AL does not
elicit any detectable effects in cortical neurons not
expressing AlstR.
In addition to these normal and EGFP-only controls,
three ferrets injected with AAV1-AlstR-EGFP in Area 17
showed extremely low AlstR expression (as inferred
from anti-EGFP staining; see the Supplemental Data).
In these cases, we did not observe any effect of AL ap-
plication, providing further support to our conclusion
that cells expressing little or no AlstR are not affected
by the doses of AL administered.
A drop in activity in the experiments described here
might be interpreted as a loss of unit isolation rather
than inactivation of the cells whose activity was being
recorded. This possibility is unlikely, as the observed re-
ductions were always rapid, nearly complete, and well-
correlated in time with AL application (e.g., Figure 5A1).
Moreover, dramatic reductions in activity such as those
observed here never occurred except in response to AL,
indicating that AL was the likely mediator of those ef-
fects. We therefore conclude that the observed drops
in activity reflect a response to AL rather than a loss of
unit isolation.
The results described here indicate that in Area 17 of
ferrets, complete inactivation of AlstR-expressing neu-
rons occurs within minutes of AL application. Recovery
of responses to 50% of baseline can occur within 40 min
when AL cannot be quickly washed out. These effects
are specific: the firing properties and gross morphology
of neurons do not appear to be affected by AlstR expres-
sion, and AL has no detectable effect on non-AlstR-
expressing neurons.
Inactivation of Neurons in Ferret LGN
To investigate whether the AlstR/AL system can effec-
tively inactivate neurons in thalamus, we injected
AAV2-AlstR-EGFP into LGNs of adult ferrets. Extracellu-
lar recordings were made from the virus-infected re-
gions of anesthetized, paralyzed ferrets after establish-ment of AlstR expression. Ferrets viewed drifting
grating stimuli on a computer monitor while AL or saline
was pressure-injected into the region through separate
barrels of a glass micropipette positioned in or near
the LGN.
AlstR/AL-mediated inactivation in ferret LGN was
rapid and complete. In the multi-unit recording shown
in Figure 6A1, conducted in an LGN infected with
AAV2-AlstR-EGFP, an initial injection of saline (2 ml at
t = 5 min) resulted in a small pressure artifact. A subse-
quent injection of AL (2 ml of 0.1 mM at t = 11 min) elicited
a slightly larger firing rate reduction. Lack of complete
inactivation here is probably due to reflux of cerebro-
spinal fluid into the pipette tip over the course of the
experiment, as evidenced by the rising level of the
meniscus observed in the pipette; this would cause
the injected fluid to consist largely of cerebrospinal fluid
with very little AL. A second AL injection (2 ml of 0.1 mM)
from the same pipette, just 12 min later (t = 23 min),
elicited a long-lasting and nearly complete reduction in
neuronal firing and responsiveness.
After a complete drop in activity at t = 28 min (5 min
after the second AL injection), cells remained inactive
for about 20 min and then gradually recovered to above
baseline firing rates at t = 88 min, delineating an approx-
imate 60 min time window for complete recovery. Be-
cause surrounding brain structures do not permit wash-
out of AL after injection into the LGN, this time window
represents the natural time course of recovery, which
presumably reflects the time for dissipation and/or
breakdown of AL. Two additional saline injections (2 ml
each) applied after recovery (t = 99 and 110 min) elicited
small pressure artifacts similar to that observed for the
initial saline injection. A final injection of 2 ml of 0.1 mM
AL (t = 121 min) caused a complete, albeit possibly
briefer, reduction in firing. It was unclear whether the
subsequent brief increase in measured spike rates (at
t = 142 min) reflected changes in unit isolation or true
recovery, but the experiment was concluded before
full recovery could be tested. Histological processing
confirms that recordings from this ferret were made
from the area of virus infection and that the AL-contain-
ing pipette was located in the LGN, 300 mm lateral to the
recording site (Figures 6A2 and 6A3).
The effects of AL were examined in three additional
LGN recordings from three AlstR-expressing ferrets.
Of these, one recording showed AL-induced inactivation
and two failed to inactivate. In the former, the spike rate
fell to 15% of baseline levels within 5 min of AL injection
and remained near zero for over 4 hr. In the latter two re-
cordings, cells fired at 84.4% and 139% of baseline
levels following AL injection. In all three cases, examina-
tion of processed brain sections confirmed correct
placement of both the recording electrode and the
AL-containing pipette (see Experimental Procedures
for inclusion criteria). Potential reasons for lack of inac-
tivation in the latter two cases are discussed below.
AL injection had no effect on firing rates of LGN cells in
control ferrets. Figure 6B1 shows firing rates, both spon-
taneous and visually evoked, from a multi-unit recording
made in the LGN of a normal, non-virus-infected ferret.
Two injections of AL at a 100-fold increased concentra-
tion (10 mM, 2 ml each) were administered during the
40 min recording session. In neither of these cases did
Reversible Inactivation of Mammalian Neurons
163Figure 6. The AlstR/AL System Can Quickly and Reversibly Inactivate Ferret LGN Neurons
(A1 and B1) Multi-unit recordings from LGN of an AlstR-expressing (A1) and a non-virus-injected control (B1) ferret. Format of plots are same as in
Figure 5; note different stimulus contrasts used. Arrows indicate times of injections of saline or AL into or near the LGN. AlstR-expressing neu-
rons inactivated in response to AL (gray arrows) but not to saline (white arrows); recovery occurs approximately 60 min later. Control neurons
were not affected by AL.
(A2, A3, B2, and B3) Histology from ferrets shown in A1 and B1, respectively. LGN in (A) was stained for EGFP; LGN in (B) was stained for cyto-
chrome oxidase. Arrows mark tracks from recording electrodes ([A2] and [B2]) and from the pipette used to inject AL ([A3] and [B3]); the pipette
was located 300 mm medial and 450 mm lateral to the electrode for (A3) and (B3), respectively. Two electrode tracks are present in (A2) (arrows)
and the recordings shown in (A1) are from the more anterior penetration. Scale bars, 250 mm; top, dorsal; left, anterior; hipp, hippocampus.injection of AL noticeably reduce the firing rate. Histo-
logical processing from this ferret confirms that the
recording was made in the LGN and that the injection
pipette was located near the LGN, 450 mm medial to
the recording site (Figures 6B2 and 6B3).
Similar results were observed in additional recordings
from control ferrets (n = 12 recordings, one normal fer-
ret, one ferret infected with AAV2-EGFP), even at 1000
times the effective AL dose (100 mM). On average, con-
trol neurons fired at 87.4% 6 5.2% of baseline firing
rates following injection of AL. The slight decrease in fir-
ing rate most likely reflects a loss of unit isolation over
the course of the experiment, rather than a reduction
caused by AL. Processing of brain sections confirmed
proper placement of the recording electrode and
AL-containing pipette. Taken together, these observa-
tions indicate that AL does not have any apparent
endogenous effects on thalamic neurons.
The experiments described here demonstrate that it is
possible to inactivate ferret LGN cells using the AlstR/AL
system. When inactivation occurs, it is quick, complete,
and long-lasting. Effects are specific, as application of
AL does not affect the activity of cells not expressing
AlstR. There are cases, however, where inactivation
was not achieved. In these cases, several explanations
are possible. The most likely explanation is that AL did
not reach cells at the recording site in some cases, likelybecause the distance between recording electrode and
AL-containing pipette was greater than estimated by our
methods, as it is difficult to pinpoint the exact locations
of the electrode and pipette tips. Even when the elec-
trode and pipette were well-positioned, AL may not
have successfully traversed the distance of dense
subcortical tissue to reach its site of action. A second
possibility is that recordings were from non-AlstR-
expressing cells despite being in a virus-infected region,
as we cannot correlate our recordings to virus infection
on a cell-by-cell basis. Finally, it remains a possibility
that AL does not reliably inactivate AlstR-expressing
cells in ferret LGN, even when it reaches those cells in
appropriate concentrations. Because it was impossible
to control all variables in these experiments, and
because we have few recordings from ferret LGN, it
is difficult to determine unequivocally which of these
potential explanations is correct.
Inactivation of Neurons in Monkey LGN
The AlstR/AL system is a tool that could prove very use-
ful in organisms such as monkeys, where neural struc-
ture/function/behavior relationships are heavily studied
but standard transgenic methods for manipulating
gene expression are not practical. To test whether the
AlstR/AL system can effectively inactivate monkey
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monkey and tested responses of LGN cells to AL.
AAV2-AlstR-EGFP was injected into the LGN of a ma-
caque monkey. Virus was injected into all layers of the
LGN and in regions that spanned a range of parafoveal
receptive fields (2–20º azimuth [az], 212–0º elevation
[el]), as determined from electrical recordings made
from the virus-containing pipette immediately prior to
virus injection. Extracellular recordings were then
made from the LGN of the monkey during four recording
sessions conducted approximately 1, 1.5, 2, and 16
months after virus injection. The monkey was anesthe-
tized and paralyzed for each recording session, during
which optimized drifting grating stimuli were presented.
Responses to visual stimuli, as well as spontaneous fir-
ing rates, were recorded before and after pressure injec-
tion of AL through a glass micropipette positioned in or
near the LGN.
Figure 7 shows the results from a representative
recording session. The first recordings of this series,
shown in Figure 7A, were from multiple units that had
a receptive field location outside of the range covered
by our virus injections (0.7º az, 24.8º el). Firing rate
and visual responsiveness did not change in response
to AL injection, presumably due to lack of AlstR expres-
sion at the recording site. In two additional recordings
from this penetration, neurons similarly did not inacti-
vate following additional AL injections.
After repositioning the electrode to a location where
recorded receptive field positions more closely matched
those at the sites of virus injection, a second set of re-
cordings was made. The recordings shown in Figure 7B,
conducted 4 hr after those shown in Figure 7A and rep-
resentative of the second set of recordings, responded
to visual stimulation at 5.4º az and 211.1º el. Activity
dropped briefly and recovered in response to the initial
two injections of 0.2 mM AL. Lack of complete inactiva-
tion in these cases is likely due to reflux of cerebrospinal
fluid into the tip of the pipette, as evidenced by changes
in the position of the meniscus observed within the
pipette; this is a strong possibility in light of the small
volumes injected (0.3 ml and 0.5 ml, respectively). After
a third AL injection (1.5 ml of 0.2 mM), cells inactivated
completely: activity fell to 11.1% of baseline values
within 5 min of AL injection, and cells inactivated com-
pletely within 10 min of AL injection.
After inactivation of the cells shown in Figure 7B, more
than 60 min elapsed without recovery. At this time, the
electrode was advanced ventrally in small increments,
covering a distance of 600 mm. There was very little re-
corded activity along this stretch of LGN, likely reflecting
continued inactivation of most neurons in the vicinity.
We were, however, able to occasionally locate weakly
visually responsive neurons along this stretch. One
such neuron, recorded 90 min after the previous AL in-
jection, completely inactivated in response to a new
AL injection (1.8 ml of 0.2 mM). Five minutes later the elec-
trode was moved again, and 130 min after the previous
AL injection, another visually responsive neuron was
isolated. Data from this recording are illustrated in Fig-
ure 7C. The neuron quickly inactivated and recovered
several times in response to repeated injections of AL
(0.4–0.8 ml of 0.2 mM). This recording is likely reflective
of atypical neurons, perhaps expressing low levels ofFigure 7. The AlstR/AL System Can Quickly and Reversibly Inacti-
vate Monkey LGN Neurons
Recordings at three different sites ([A]–[C]), all from the same record-
ing session in the LGN of a monkey expressing AlstR, are illustrated
in chronological order. Format of plots is the same as in Figure 5
(note different stimulus contrasts used). (A) Recording from a single
unit whose receptive field location was outside of the range covered
by AlstR virus injections. This cell was not affected by addition of AL,
presumably due to lack of AlstR expression. (B) Multi-unit recording,
made 4 hr after the recording shown in (A); this recording was from
a new penetration where receptive fields aligned with those at the
site of AlstR virus injection. AL injections resulted in complete silenc-
ing so that even responses to optimal stimuli were eliminated.
Inactivation remained nearly complete for approximately 70 min;
very little activity could be detected, even at other sites within
600 mm of this site when the electrode was repositioned 90 min after
AL injection. (C) Single-unit recording made from the same penetra-
tion as in (B), 130 min after the last AL injection indicated in (B). This
cell inactivated and recovered quickly and repeatedly in response to
repeated AL injections.
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Reversibly Inactivates Mouse Spinal Motor
Neurons
Ventral root electroneurogram recordings
from left L2 and left L5 ventral roots in iso-
lated spinal cords of P0 nestinCre; AlstR192
mice. Recordings shown at the top are at
a slow timescale while insets show selected
points at a faster timescale. Rhythmic motor
activity was induced by drug application to
the preparation (see Experimental Proce-
dures). The rhythmic activity alternating
between the L2 and L5 ventral roots can be
seen in the first inset. After adding 1 mm AL
to the bath, activity gradually reduced over
the next 5–10 min. Reduced activity and dis-
rupted rhythmicity are apparent in the second
inset, and nearly complete inactivation of mo-
tor activity is apparent in the third inset. After
the AL is washed out of the bath, normal ac-
tivity gradually recovers and appears similar
to activity before AL.AlstR: such neurons would be less sensitive to AL and
able to recover from inactivation more quickly. In the re-
cordings shown here, it is likely that the initial AL injec-
tion was insufficient to elicit long-lasting inactivation,
whereas subsequent injections transiently increased
the local AL concentration adequately to briefly abolish
activity.
As illustrated above, we found cells that were both re-
sponsive and unresponsive to AL in each of our first
three recording sessions in monkey. In cases where in-
activation was not observed, there are several potential
explanations: (1) recordings may have been made from
non-AlstR-expressing cells; (2) the AL pipette may
have been far from the recording site, making it impos-
sible for critical concentrations of AL to reach the cells
being recorded; and (3) cerebrospinal fluid, rather than
AL, may have been injected from the pipette tip due to
reflux. The first two are very likely possibilities, as we
had no histological confirmation of electrode or pipette
positions following our recording sessions. In view of
the observation that nearly all neurons appeared to be
inactivated in a particular region whenever inactivation
was observed (see above), other explanations, such as
variability in intrinsic properties of neurons or suscepti-
bility to inactivation by these methods, seems unlikely.
Because our number of recordings is small, it remains
a formal possibility that, even under ideal conditions,
AL-induced inactivation might not occur reliably in the
monkey LGN.
A fourth recording session was conducted in the same
monkey, 16 months after injection of virus into the LGN.
In this session, we performed just one recording from
a group of cells with a receptive field of 11.4º az,
26.7º el. Although this receptive field location corre-
sponds to the area injected with virus, we did not
observe a response to AL. This could be due to dropoff
of AlstR expression during the 16 month period follow-
ing virus injection. However, because AAV2 has been
shown to confer stable gene expression lasting more
than 18 months (Xiao et al., 1997), the lack of inactivation
is more likely to be due to one of the reasons describedabove. Because we did not process histological sec-
tions from this monkey, we have no physical indication
of what the AlstR levels were.
Inactivation of Neurons from Mouse Spinal Cord
Mice are an excellent mammalian species for manipulat-
ing gene expression and have been widely examined in
a variety of research areas, making them an ideal organ-
ism for future applications of the AlstR/AL system. To
examine whether the AlstR/AL system can reversibly
silence neurons in transgenic mice, we generated trans-
genic mice that conditionally express AlstR and EGFP
following Cre recombination (AlstR192 mice). We de-
scribed these mice in a previously published study in
which AL-induced, reversible inactivation of a specific
class of spinal cord inhibitory neurons was shown to re-
sult in specific changes in locomotor activity (Gosgnach
et al., 2006). We reiterate the utility of these mice here by
illustrating effects of more widespread inactivation of
spinal cord neurons. In these experiments, the AlstR192
mice were crossed with mice expressing Cre from the
nestin promoter (nestinCre; AlstR192 mice), which re-
sults in widespread expression of EGFP (and presum-
ably AlstR) throughout the population of spinal cord
neurons (Gosgnach et al., 2006). Locomotor-like oscilla-
tions, characterized by repetitive oscillatory bursting of
motor neurons, were induced in the isolated spinal
cord by applying the excitatory neurotransmitter ago-
nists N-methyl-D-aspartate and 5-hydroxytryptamine
(Gosgnach et al., 2006). Before addition of AL, agonists
induced a pattern of alternating left flexor activity (lL2)
and left extensor activity (lL5) in spinal cords isolated
from nestinCre; AlstR192 mice (Figure 8). Application of
1 mM AL strongly silenced rhythmic motor activity, and
washout of AL resulted in recovery of rhythmic motor
activity within 5 min. In contrast, allatostatin (100 nM–
5 mM) had no effect on rhythmic motor activity in isolated
spinal cords of control mice (data not shown). These re-
sults indicate that the AlstR/AL system can be used to
inactivate neurons from transgenic mice in a selective
and quickly reversible manner.
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Here we have shown that the AlstR/AL system is an
effective genetic method for quick and reversible inacti-
vation of mammalian neurons in vivo. Using AAV to
express AlstR in thalamic and cortical neurons of rat, fer-
ret, and monkey, we have demonstrated that the AlstR/
AL method can effectively inactivate both field potential
and single-unit activity. Application of AL also resulted in
reversible inactivation of spinal cord neurons of trans-
genic mice conditionally expressing AlstR. Taken to-
gether, these results indicate that the AlstR/AL system
can be used in vivo to effectively inactivate a wide range
of neuron types in a variety of mammalian systems.
In addition to its versatility, the AlstR/AL system has
many features that make it well-suited for detailed stud-
ies of neural circuitry, perception, and behavior. An
important feature of this system is its high degree of
specificity. Even at 100–1000 times the effective dose,
AL does not have detectable effects on neurons not
expressing AlstR. Moreover, AlstR is unresponsive to
a variety of common mammalian peptides (Birgul
et al., 1999), suggesting that expression of AlstR alone
does not affect the excitability of AlstR-expressing cells.
This is consistent with our observation that visual neu-
rons had normal activity levels and tuning properties in
the absence of AL. These characteristics make the
AlstR/AL system ideal for targeting cells for inactivation
without unwanted side effects.
Another attractive feature of the AlstR/AL system is its
potency. Application of AL to neurons expressing AlstR
could completely inhibit spiking, leaving no residual ac-
tivity, even to optimized visual stimuli. AL also very reli-
ably inactivated cortical LFP activity in rats expressing
AlstR. Although some activity remained after AL applica-
tion, in most cases this residual activity likely represents
the activity of neurons with low levels or no expression
of AlstR. This conclusion is supported by our single-
unit recordings in ferret and monkey, where spiking
could be completely abolished in individual neurons.
All of our results are consistent with the conclusion
that when AL reaches AlstR-expressing neurons, inacti-
vation is reliable and complete. When inactivation was
not observed, it is likely that either AL did not reach
the AlstR-expressing neurons or the recorded neurons
did not express AlstR. In our LGN experiments, we en-
countered difficulties in assuring that AL was delivered
to the AlstR-expressing cells. In some of these cases,
we could not later verify whether recorded neurons ex-
pressed AlstR, thus confounding clear interpretation of
the cause of the negative result. Because of these limita-
tions, our method will prove easiest to use when applied
to neurons that can be readily accessed by AL—on the
cortical surface or in subcortical structures adjacent to
a ventricle, for example. Although we cannot rule out
the possibility that the AlstR/AL system is unable to in-
activate some LGN cell types, our results remain consis-
tent with the potential for inactivation of all cell types.
The time course of AL-mediated inactivation and
recovery makes it ideal for many physiological and be-
havioral studies. The temporal resolution of AlstR/
AL-mediated inactivation is limited only by the speed
with which AL can be delivered and then removed. The
primary factors influencing speed of inactivation there-fore appear to be diffusion and proximity. Even when
AL is applied up to 1 mm distally (e.g., cortical neurons
far from the brain surface), AlstR-expressing cells inac-
tivate within minutes, indicating that the time limitation
posed by these factors is minimal. Inactivation persists
without desensitizing in the continued presence of AL,
and recovery is similarly rapid when AL is efficiently
removed from the area, as in our rat LFP experiments.
Recovery occurs more slowly when AL is not easily re-
moved: in our ferret experiments, for example, recovery
typically required an hour or more. The ability to achieve
inactivation within minutes and maintain that inactiva-
tion for extended periods of time makes it a very useful
method for physiological studies.
In these experiments, we studied the effects of direct
application of AL to neurons. We did not test the possi-
bility of inactivation by delivering AL to the ventricles or
systemically. AL delivered to the ventricle is likely to in-
activate AlstR-expressing neurons along or near the
ventricular surface, as AL was able to inactivate neurons
when applied to surfaces 1 mm distally in our cortical ex-
periments. Systemic delivery may not be as successful,
as a peptide such as AL is unlikely to cross the blood-
brain barrier. For this reason, future development of
small-molecule AlstR ligands capable of overcoming
this limitation would be helpful. However, systemic ad-
ministration would likely result in some loss of temporal
control and would eliminate specificity obtainable by
applying AL locally. The level of temporal control could,
nevertheless, be satisfactory for conducting behavioral
experiments.
Several genetic methods for perturbing neuronal
activity exist, and the choice of method for a particular
application will depend on the temporal resolution de-
sired. Light-based methods (Banghart et al., 2004; Boy-
den et al., 2005; Li et al., 2005; Lima and Miesenbock,
2005; Zemelman et al., 2002, 2003) offer millisecond
temporal control, and are ideal for studying issues
such as the effects of spike timing on synaptic plasticity.
The MIST system (Karpova et al., 2005) reversibly blocks
synaptic transmission with temporal control on the
order of hours: such a system is well-suited for behav-
ioral studies, in which the desired period of inactivation
is hours to days. A disadvantage of this method is that
the extent of transmission block has not been directly
measured in vivo and therefore remains unknown.
Long-term inactivation of neurons via temporally regu-
lated gene expression (e.g. Johns et al., 1999) are best
suited for studies of development and plasticity, where
the desired period of inactivation is days to weeks. Fi-
nally, the AlstR/AL system holds a unique position as
a method with a temporal resolution ideal for electro-
physiological studies of circuit function: the timescale
of this method is rapid enough to allow direct compari-
sons of a normally functioning circuit with its selectively
inactivated counterpart within the brief period during
which stable recordings can be obtained.
In conclusion, the AlstR/AL system is a promising
method for reversibly inactivating mammalian neurons
in vivo on a timescale of minutes and extending up to
hours. Here, we have shown that the AlstR/AL method
can be used in a variety of mammalian systems, demon-
strating its wide applicability. When combined with
promoter-based, cell-type-specific expression, this
Reversible Inactivation of Mammalian Neurons
167method will greatly advance our understanding of neural
circuits and behavior (Gosgnach et al., 2006). In the fu-
ture, in vivo development of other genetically based
methods for altering neural excitability will likely com-




AAV was prepared according to methods described previously (Ra-
binowitz et al., 2002; Xiao et al., 1998; Zolotukhin et al., 1999). AAV
was generated by transfection of 293T cells in 150 mm dishes with
22.5 mg of pXX6-80 (Ad5 genome), 7.5 mg of either pXR1 (for serotype
1) or pXX2 (for serotype 2), and 7.5 mg of a cloning vector containing
an expression cassette flanked by the AAV ITRs by using lipofect-
amine 2000 (Invitrogen) according to the instructions. Cells were
harvested at 48–72 hr after transfection, resuspended in 15 ml of
Gradient Buffer (10 mM Tris [pH 7.6], 150 mM NaCl, 10 mM MgCl2),
subjected to four cycles of freeze/thaw in addition to passing
through a syringe with a 21G–23G needle, and treated with
50 U/ml of Benzonase (Sigma) for 30 min at 37ºC. Clarified superna-
tants containing AAV were obtained by centrifugation (3000 3 g,
15 min, 4ºC), and virus was purified using iodixanol gradients as
described elsewhere (Zolotukhin et al., 1999). The titer of AAV
genome-containing particles per milliliter was determined by real-
time PCR using SYBR Green I double-stranded DNA binding dye
and an ABI Prism 7700 sequence detection system (PE Biosystems).
Four viral constructs were used in this study. These viruses dif-
fered from each other only in the genetic sequence that was pack-
aged into the viral genome and/or the capsid protein (serotype 1
or 2). The viruses were (1) an AAV1 containing an AlstR-IRES2-
EGFP expression cassette under the control of a synapsin promoter
(termed ‘‘AAV1-AlstR-EGFP,’’ initial titer 9.2 3 1011 particles/ml);
(2) an AAV2 containing the same promoter and cassette (termed
‘‘AAV2-AlstR-EGFP,’’ initial titer 1.35 3 1010 particles/ml); (3) an
AAV1 encoding EGFP under the control of a CMV promoter (termed
‘‘AAV1-EGFP,’’ initial titer 1.5 3 1011 particles/ml); and (4) an AAV2
encoding EGFP under the control of a synapsin promoter (termed
‘‘AAV2-EGFP,’’ initial titer 3.83 3 109 particles/ml).
Rat Experiments
All animal procedures described in the Experimental Procedures
section were approved by the Salk Institute Animal Care and Use
Committee.
Virus Injections
Six rats aged 33–37 days postnatal at the time of AAV injection were
used in this study. Rats were initially anesthetized in a chamber con-
taining 2.5% isoflurane. Animals then were intubated and placed in
a stereotaxic apparatus, with anesthesia maintained using inhaled
isoflurane (1.5%–2% in oxygen). End-tidal CO2 (EtCO2), Pulse oxy-
gen (SpO2), and heart rate were monitored continuously to judge
the animals’ health and to maintain proper anesthesia levels. A small
craniotomy was then made over the area of interest, and the under-
lying dura was slit in several locations to allow penetration by the
virus-containing pipette. AAV was pulled into a glass micropipette
(w30 mm tip diameter) by suction, and injected by pressure using
a Picospritzer II (General Valve Corp.) at a rate of 0.2–2 ml/min in
10–20 ms bursts of pressure (10–40 psi). A total of 5–8 ml of virus
was typically injected at 3–5 sites at depths of 300 mm, 600 mm,
and 1 mm from the cortical surface. After virus injections, Gelfoam
(Pharmacia & Upjohn Company, MI, USA) was placed over the cra-
niotomy and the scalp was sutured shut. We then waited 3–9 weeks
for expression of AlstR and/or EGFP.
Field Potential Recording and Data Collection
Field potential recordings were made at least 35 days after AAV in-
jection, and at this time rats were aged 71–122 days postnatal
(‘‘adult’’). In preparation for recording, rats were initially anesthetized
in a chamber containing 2.5% isoflurane in oxygen. Animals were
then intubated and surgical anesthesia was maintained using
1.5%–3% isoflurane in oxygen. After placing the rat in a stereotaxic
apparatus, the scalp was retracted to expose the pre-existing crani-
otomy; the craniotomy was expanded as necessary if healing hadoccurred. The dura and scar tissue around the site of virus injection
was removed. Following the initial surgical procedure, anesthesia
was maintained with 1%–1.5% inhaled isoflurane: EKG, SpO2,
EtCO2, and heart rate were monitored continuously to judge the an-
imal’s health and to maintain proper anesthesia levels. Whiskers
were then trimmed contralateral to the recorded barrel cortex and
the cheek pierced with 27G needles used to stimulate the whisker
pad with an electric pulse (10 V, 1 ms duration, 0.1 Hz) generated
from a Grass S44 stimulator and SIU5 stimulus isolation unit (Grass
Instrument). LFP recordings were made using epoxylite-coated
tungsten electrodes (1 MU resistance, FHC, Bowdoinham, ME).
Signals from 300 Hz to 10 kHz were passively filtered and amplified
using a DAM-50 amplifier (WPI) and actively filtered at 60 Hz using
a HumBug (Quest Scientific), and sent to a computer running custom
LabVIEW 7.1 software (National Instruments) for data storage.
AL and Saline Application
The Drosophila allatostatin peptide Ser-Arg-Pro-Tyr-Ser-Phe-Gly-
Leu-NH2 (Birgul et al., 1999) was synthesized in-house and stored
in 100 mM aliquots in water at 280ºC. For experiments, AL was
diluted to its final concentration in saline (0.9% NaCl) and stored
on ice until use. To test effects on cortical neurons, a saturating vol-
ume of AL was dropped onto the cortical surface using a handheld
manual pipette. For saline washes, fluid from the craniotomy was
absorbed by applying a cotton swab to the portion of skull surround-
ing the craniotomy. After removal of most fluid from the craniotomy,
additional saline was then applied. This procedure was repeated
several times for a given wash.
Data Analysis
Field potentials recorded in rat barrel cortex were collected at a sam-
pling rate of 10 kHz for a duration of 0.5 s, beginning 5 ms prior to
each electrical stimulus. We used LabVIEW 7.1 software to control
stimulus timing and NI DAQPad-6015 (National Instruments) for
data acquisition. To correct for rapid fluctuations in the LFP, raw
data were smoothed by replacing the value at each time point by
the average of 10 values preceding and following that data point.
All subsequent analyses were then based on these smoothed
LFPs (e.g., Figure 2). Peak values, taken as the highest positive value
in the signal after termination of the stimulus artifact, were then plot-
ted for the entire length of the experiment as shown (e.g., Figure 3).
An alternative analysis used the total area under the initial positive
deflection of the LFP as a quantitative measure of the response to
whisker stimulation and yielded essentially the same results (see
Results).
To estimate the effects of AL on LFP activity, changes in LFP
peaks and areas following AL application and recovery were com-
pared to the effects of muscimol. Since muscimol presumably
results in complete inactivation of cortical neurons, any activity
remaining after muscimol is assumed to reflect contributions from
other sources, such as afferent axons terminating in the recorded
region. Therefore, the average LFP values during the final 3 min of
recordings following muscimol application were defined as a base-
line value and subtracted from all other LFP measures. Percent inac-
tivation and recovery were calculated as the average LFP response
during the 3 min following AL application and saline washout, re-
spectively, divided by the average response 3 min prior to AL appli-
cation, multiplied by 100.
Histology
After cortical recordings, electrolytic lesions (23 to 24 mA, 3–5 s)
were made to mark the recording site. In some experiments, elec-
trodes were coated with DiI (0.25% in 100% ethanol, then dried) to
aid recording site identification. After lesions were made, the animal
was deeply anesthetized with an overdose of sodium pentobarbital
(>100 mg/kg, i.p.). The animal was then perfused transcardially with
a phosphate buffered saline (PBS) rinse, followed by fixation with
4% paraformaldehyde in PBS. The brain was removed and cryopro-
tected overnight in a solution containing 30% sucrose in PBS. It was
then frozen and cut sagittally into 40 mm sections using a freezing mi-
crotome. Cytochrome oxidase (CO) staining was performed using
methods described elsewhere (Wiser and Callaway, 1996). Sections
were then antibody-stained for EGFP as follows: endogenous per-
oxidase activity was quenched using 10% hydrogen peroxide in
PBS, and sections were incubated in a blocking buffer (10% normal
goat serum, 2% bovine serum albumin, 0.25% Triton X-100, in PBS).
Sections were then incubated in a rabbit polyclonal antibody against
Neuron
168EGFP (Molecular Probes, 1:1000 in blocking buffer), followed by an
incubation in a biotinylated anti-rabbit secondary antibody (Vector
Laboratories, 1:200 in blocking buffer). Sections were then incu-
bated in an HRP-conjugated avidin-biotin complex (ABC Peroxidase
Standard Kit, Vector Laboratories), and HRP localization was
revealed by reacting the sections in a solution containing 0.05%
DAB, 0.028% cobalt chloride, 0.02% nickel ammonium sulfate,
and 0.0015% hydrogen peroxide in PBS. Finally, sections were
mounted on gelatin subbed slides, dried, dehydrated, cleared, and
coverslipped in Permount (Fisher Scientific).
Ferret Experiments
Fifteen adult female ferrets (Mustela putorius furo, 0.7–1 kg) were
used in this study. Ten ferrets were used in cortical studies, and
for each of these, AAV was injected into Area 17 of a single hemi-
sphere. Of these ten ferrets, eight were injected with AAV1-
AlstR-EGFP and two with AAV1-EGFP. One animal injected with
AAV1-AlstR-EGFP received recordings only in the noninjected hemi-
sphere; one animal injected with AAV1-EGFP received recordings
from both injected and noninjected hemispheres. All others received
recordings only in the injected hemisphere. Five ferrets were used in
the LGN studies, and four of these had AAV injected into the LGN in
a single hemisphere; three were injected with AAV2-AlstR-EGFP and
one with AAV2-EGFP. All four of these animals received recordings
in the injected hemisphere. LGN recordings were also made from
a fifth ferret that was not injected with AAV.
Virus Injections
Virus injections in ferret visual cortex were performed as described
above for rat experiments, with the following exceptions. Record-
ings were first made with a tungsten electrode to identify potential
injection sites (see below for recording methods); a silver wire was
then inserted into the virus-containing pipette for electrical confir-
mation of receptive fields at the sites of virus injection. A total of
4–8 ml of virus was typically injected at several depths along two to
four penetrations of the cortex per ferret. Additionally, red and green
latex microspheres (LumaFluor, Inc) were injected near the site of
virus injection to facilitate subsequent identification of the virus-
infected area for recording purposes.
Virus injections in ferret LGN were performed as described above
for cortical injections, with the following exceptions. Ferrets were
initially anesthetized with an intramuscular injection of 40 mg/kg ket-
amine prior to intubation and subsequent maintenance of anesthe-
sia with inhaled isoflurane. Virus was targeted to the ventral portions
of the LGN, corresponding to central visual fields. A total of 8–12 ml of
virus was typically injected along two to four penetrations per ferret
LGN.
Electrophysiological Recordings
Surgical preparation for recording was conducted as described
above for rats, except that ferrets with LGN virus injections were ini-
tially anesthetized with an intramuscular injection of 40 mg/kg ket-
amine rather than in a chamber containing isoflurane. Additionally,
dexamethasone (0.5 mg/kg) and atropine (0.05 mg/kg) were admin-
istered to all ferrets intramuscularly in order to reduce brain swelling
and salivation, respectively. For stabilization of cortical recordings
in some ferrets, cerebrospinal fluid (CSF) was removed from the ven-
tricle via a cisternal puncture, creating a large gap between the skull
and brain surface. Even when CSF was not removed, a sizeable gap
(w1 mm) existed between the skull and brain of the ferret.
Following the initial surgical procedure, anesthesia was main-
tained with 1%–2% inhaled isoflurane (LGN recordings) or 0.5%–
1% isoflurane in a 2:1 mixture of oxygen and nitrous oxide (cortical
recordings). Ferrets were paralyzed with pancuronium bromide
(0.1–0.2 mg/kg/hr, i.v. or i.p.) and artificially ventilated. Pupils were
dilated with 1% atropine, nictitating membranes were retracted
with 1% phenylephrine hydrochloride, and corneas were protected
with noncorrective, gas-permeable contact lenses. EEG, EKG,
SpO2, EtCO2, heart rate, and body temperature were continuously
monitored to judge the animal’s health and to maintain proper anes-
thesia levels.
Recordings were made using epoxylite-coated tungsten elec-
trodes (FHC, Bowdoinham, ME) of 2–5 MU resistance. Before col-
lecting data, receptive fields were tested for correspondence with
those recorded at the time of virus injection (in cortical experiments,
latex microspheres aided in correct electrode placement). Signalswere passively filtered and amplified using a DAM-50 amplifier
(WPI), and actively filtered at 60 Hz using a HumBug (Quest Scientific);
spikes were sorted online and spike times were stored, along with
stimulus parameters, using custom software (PEP, Dario Ringach).
In some cortical experiments, data were collected using quartz/
platinum-tungsten electrodes and a multielectrode drive (Mini-05 mi-
crodrive, Thomas Recording Inc; electrode impedances 1–2 MU).
Neuronal signals were recorded extracellularly and waveforms
were stored using the Multichannel Acquisition Processor system
(Plexon, Inc). Single neurons were isolated on-line for analysis with
Rasputin software (Plexon, Inc), and again off-line with Plexon Off-
line Sorter (Plexon, Inc).
Visual Stimulation
Stimuli were generated by a Silicon Graphics O2 computer, 24-bit
color, using custom software (PEP, Dario Ringach) and were
displayed on an SGI GDM-17E21 CRT display at 100 Hz refresh
rate. Stimuli were typically circular patches of drifting sinusoidal
grating, of radius 1º–2º, presented on a constant gray background
(each linearized gun at half-maximal intensity), of mean luminance
w28 cd/m2. Stimuli were shown for 4 s at a distance of 100 cm from
the animal. For some minimally responsive neurons, a square-wave
grating was shown on a black background for the entire recording
session. Stimulus location, spatial and temporal frequencies, and
orientation were optimized, and stimulus parameters were kept con-
stant for each unit. Each stimulus was presented twice, and a blank
trial appeared after each grating stimulus to acquire a measure of
spontaneous firing rate.
AL and Saline Application
For cortical recordings, AL application and saline washes were per-
formed as described above for rat experiments. For LGN experi-
ments, AL was drawn into a glass micropipette similar to those
used for virus injections. The micropipette was inserted at an angle,
and its tip was positioned at the same depth as, and 0.5–1 mm away
from, the tip of the recording electrode. In some experiments, a silver
wire inserted into the AL-containing pipette enabled electrical re-
cordings, and the pipette’s position in the LGN was confirmed by de-
tection of visually responsive cells with peripheral receptive fields.
AL was injected from the micropipette by pressure as described
for virus injections using a Picospritzer II (General Valve Corp.).
In some LGN experiments, saline and AL were injected through
separate barrels of a triple-barrel pipette. In these cases, pipettes
were pulled on a List-Medical puller (L/M-3P-A) from standard-wall
triple-barrel capillary glass (FHC), and tips were broken to about
40 mm. Barrels were back-filled using MicroFil needles (WPI), poly-
ethylene tubing was inserted into the ends of the barrels, and
quick-setting epoxy was applied at the junction to create an airtight
seal. Positioning of the pipette, electrophysiological confirmation of
LGN placement, and AL injection were conducted as described
above.
Data Analysis
For both cortical and LGN experiments, mean spike rates in re-
sponse to two presentations of each visual stimulus were averaged
and plotted as shown in the Results. In Figure 4, spontaneous firing
rates represent average responses to blank trials presented during
a single stimulus set; in Figures 5 and 6 and Figure S1 in the Supple-
mental Data, spontaneous firing rates are calculated from blank tri-
als presented throughout the entire length of the recording session.
For calculations of silencing and recovery in cortical experiments,
responses to 99% contrast visual stimuli were used. Baseline was
taken as the average response during the 10 min (or fraction thereof,
if data was not collected for 10 min) preceding AL application, re-
gardless of AL concentration. Responses were averaged over
5 min bins following any fluid application. Percent remaining activity
after AL treatment was calculated from the 5–10 min bin following
application of 0.1 mM AL (two ferrets) or 0.05 mM AL (one ferret); in
one case, a 0.01 mM concentration of AL had been previously ap-
plied, with no effect. Recovery was taken as the 5 min bin yielding
the highest average response to a 99% contrast stimulus after appli-
cation of the saline wash. Responses during these 5 min bins were
divided by baseline responses to yield the silencing and recovery
indices reported.
In control experiments conducted in ferret cortex, no reduction in
firing was observed in response to AL applied in a range of doses
from 0.1–10 mM. To calculate percent remaining activity in these
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application were averaged to yield a single mean response for
each ferret. This response was then divided by the baseline re-
sponse to yield the silencing index shown in results. All calculations
were made using responses to 99% contrast stimuli.
In LGN experiments, AL was injected multiple times during multi-
ple recordings for a given animal. In order to eliminate possible ef-
fects of previous AL applications from our analysis, we included in
our analysis only responses to the first AL injection from the first re-
cording in each ferret in which AL was applied (with one exception;
see below). For both AlstR-expressing and control ferrets, inactiva-
tion was calculated as described for cortical experiments. Because
no response to AL was observed in control ferrets, recordings were
included in our analysis even if AL had been previously applied.
The following are criteria for exclusion of recordings, both cortical
and thalamic unless otherwise indicated, from our analysis: (1) AL
had previously been applied to the area, (2) cells were not visually
responsive, (3) the recording site could not be identified after the ex-
periment, (4) the recording site was found to lie outside of the virus-
infected area, (5) injury discharges contributed to the spike count
during the experiment, (6) the recording did not silence upon musci-
mol application, or did not exhibit orientation tuning if muscimol was
not applied (cortical experiments only), or (7) the medial-lateral dis-
tance between the recording electrode and AL-containing pipette
was not 0.2–1 mm (LGN recordings only). The last criterion was in-
tended to exclude potential pressure artifacts while ensuring that
the AL pipette was positioned reasonably close to the electrode.
There was one exception to these exclusion criteria: one LGN exper-
iment was included in which AL had been applied 4.5 hr previously,
but the recording was made in a new electrode penetration.
Histology
Electrolytic lesions were made at the recording sites as described
above for rat experiments. Quartz/platinum-tungsten electrodes
used in some ferret recordings (see above) were incapable of pro-
ducing electrolytic lesions; in these cases, a DiI-coated tungsten
electrode was inserted after recording electrodes were retracted
and lesions were made to mark the approximate recording site. An-
imals were perfused and sections were processed for CO and EGFP
staining as described above, except that sections were 50 mm thick.
Also, following perfusion with 4% paraformaldehyde in PBS (‘‘fixa-
tive’’), ferrets were perfused with solutions of 10% and then 20%
sucrose in fixative prior to removal of the brain.
Monkey Experiments
Chamber Implantation
A recording chamber was implanted on the single Rhesus macaque
monkey (Macaca mulatta, 8 kg) used in this study; virus injections
and electrical recordings were then conducted with this recording
chamber in place. Surgery was performed under inhaled isoflurane
anesthesia (1%–1.5% in oxygen) after the monkey was sedated
with 0.01 mg/kg acepromazine and 10 mg/kg ketamine. A stainless
steel recording chamber was affixed to the skull with dental acrylic
and stainless steel screws. The chamber was centered at approxi-
mately AP +7.5 mm and ML +11.5 mm to allow microelectrode pen-
etration into the LGN along the dorsoventral axis. The chamber was
capped and the skin drawn up around the margin of the cranial
implant. After healing, the chamber was cleaned weekly with sterile
saline, 3% hydrogen peroxide, and dilute povidone-iodine.
Virus Injections
Virus was injected into the monkey LGN as described above for fer-
ret LGN experiments, with the following exceptions. The monkey
was initially anesthetized in 0.01 mg/kg acepromazine and 10 mg/kg
ketamine (i.m.); lactated Ringer’s and pancuronium bromide
(0.075–0.1 mg/kg/hr) were administered intravenously during the
surgery to maintain hydration and to paralyze the monkey. The re-
cording chamber was cleaned as described above, the dura was
thinned with a scalpel, and an incision was made in the dura to allow
penetration. Corrective, gas-permeable contact lenses were applied
to protect the corneas. As in the ferret experiments, electrical
recordings were made from the LGN both before and during virus
injections to locate potential injection sites and identify visual recep-
tive fields at the sites of injection. To aid in receptive field assign-
ments, a reversing ophthalmoscope was used to map the fovea
and blind spot in each eye. A total of 20 ml of virus (AAV2-AlstR-EGFP) was injected at several depths along three penetrations in
the monkey’s left LGN. After virus was injected, the chamber was
recapped, and the dura healed before the next recording session.
Electrophysiological Recordings
Surgical preparation for recording was conducted as described
above for ferrets, with the following exceptions. The monkey was
initially anesthetized with 0.01 mg/kg acepromazine and 10 mg/kg
ketamine (i.m.), and paralyzed with vecuronium bromide (7.5–
12.5 mg/kg/hr, i.v.) during the recording session. Phenylephrine
hydrochloride was not applied to the eyes. Additional corrective
lenses were placed in front of the eyes to focus the visual stimulus.
Appropriate magnification of lenses was determined based on re-
sponses of neurons to drifting gratings (Chatterjee and Callaway,
2002). Recordings were conducted using 2–5 MU resistance epoxy-
lite-coated tungsten electrodes; mapping of the fovea and blind spot
using a reversing ophthalmoscope aided in assignment of receptive
fields.
Visual Stimulation
Visual stimuli were displayed as described above for ferret experi-
ments. All stimuli shown in monkey experiments were circular
patches of drifting sinusoidal grating. When necessary, the color
composition of the stimulus was optimized for the neurons whose
activity was being recorded.
AL Application and Data Analysis
AL application and data analysis were conducted as described
above for ferret LGN experiments.
Mouse Electroneurogram Recordings
nestinCre; AlstR192 mice were generated as described previously
(Gosgnach et al., 2006). In vitro electrophysiological experiments
were performed on early postnatal (P0) mice in accordance with
the ethical rules stipulated by the NIH. Animals were anesthetized
and decapitated, and spinal cords were dissected out in ice-cold
Ringer’s solution (see Lanuza et al., 2004). Recordings were made
in Ringer’s solution at room temperature (20ºC) by placing the sec-
ond and fifth lumbar ventral roots (i.e., rL2, lL2, rL5, lL5) in bipolar
suction electrodes. Electroneurogram (ENG) signals were amplified,
band pass filtered (100 Hz to 1 kHz), digitized, and collected using
the Axoscope software (Axon Instruments, Foster City, CA). Rhyth-
mic locomotor activity was induced by adding N-methyl-D-aspartic
acid (NMDA, 5 mM, Sigma) and 5-hydroxytryptamine (5-HT, 10 mM,
Sigma) to the perfusing Ringer’s solution. Effects of allatostatin on
the locomotor pattern were examined by adding the peptide to the
perfusion solution.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/51/2/157/DC1/.
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